GWM
VKTX icon

Geneos Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Geneos Wealth Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-440
Closed -$1K – 2594
2022
Q2 		$1K Hold
440
– – ﹤0.01% 2550
2022
Q1 		$1K Hold
440
– – ﹤0.01% 2707
2021
Q4 		$2K Hold
440
– – ﹤0.01% 2616
2021
Q3 		$2K Hold
440
– – ﹤0.01% 2678
2021
Q2 		$2K Sell
440
-1,910
-81% -$11.3K ﹤0.01% 2695
2021
Q1 		$15K Hold
2,350
– – ﹤0.01% 2218
2020
Q4 		$2K Buy
2,350
+1,975
+527% +$12K ﹤0.01% 2732
2020
Q3 		$2K Hold
375
– – ﹤0.01% 2455
2020
Q2 		$2K Buy
+375
New +$2.49K ﹤0.01% 2393

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return